Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (451-460 of 574) with videos related to

Pageof 58
Sort By:
Current Oncology (Toronto, Ont.)|July 25, 2022
Upfront Next Generation Sequencing in Non-Small Cell Lung CancerShelley Kuang, Andrea S Fung, Kirstin A Perdrizet, et al.
Lung Cancer (Amsterdam, Netherlands)|July 30, 2022
PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLCSally C M Lau, Madhumitha Rabindranath, Jessica Weiss, et al.
Molecular Cancer Research : MCR|October 10, 2022
Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non-Small Cell Lung CancerShideh Mirhadi, Wen Zhang, Nhu-An Pham, et al.
Nature Communications|March 27, 2024
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitisPooja Middha, Rohit Thummalapalli, Michael J Betti, et al.
The New England Journal of Medicine|May 29, 2026
First-Line Sunvozertinib in NSCLC with <i>EGFR</i> Exon 20 Insertion MutationsCaicun Zhou, Laurent Greillier, Geoffrey Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitisPooja Middha, Rohit Thummalapalli, Michael J Betti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2020
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non-small cell lung cancer: A real-world multicentre studyAntoine Desilets, Félix Blanc-Durand, Sally Lau, et al.
Elife|February 22, 2023
Proliferative exhausted CD8<sup>+</sup> T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinomaDanni Cheng, Ke Qiu, Yufang Rao, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 23, 2019
Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's EsophagusShao-Hua Xie, Rui Fang, Mingtao Huang, et al.
Carcinogenesis|October 5, 2014
Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinomaMatthew F Buas, David M Levine, Karen W Makar, et al.
Pageof 58

Showing results (451-460 of 574) with videos related to

Sort By:
Pageof 58
Current Oncology (Toronto, Ont.)|July 25, 2022
Upfront Next Generation Sequencing in Non-Small Cell Lung CancerShelley Kuang, Andrea S Fung, Kirstin A Perdrizet, et al.
Lung Cancer (Amsterdam, Netherlands)|July 30, 2022
PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLCSally C M Lau, Madhumitha Rabindranath, Jessica Weiss, et al.
Molecular Cancer Research : MCR|October 10, 2022
Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non-Small Cell Lung CancerShideh Mirhadi, Wen Zhang, Nhu-An Pham, et al.
Nature Communications|March 27, 2024
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitisPooja Middha, Rohit Thummalapalli, Michael J Betti, et al.
The New England Journal of Medicine|May 29, 2026
First-Line Sunvozertinib in NSCLC with <i>EGFR</i> Exon 20 Insertion MutationsCaicun Zhou, Laurent Greillier, Geoffrey Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitisPooja Middha, Rohit Thummalapalli, Michael J Betti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2020
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non-small cell lung cancer: A real-world multicentre studyAntoine Desilets, Félix Blanc-Durand, Sally Lau, et al.
Elife|February 22, 2023
Proliferative exhausted CD8<sup>+</sup> T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinomaDanni Cheng, Ke Qiu, Yufang Rao, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 23, 2019
Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's EsophagusShao-Hua Xie, Rui Fang, Mingtao Huang, et al.
Carcinogenesis|October 5, 2014
Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinomaMatthew F Buas, David M Levine, Karen W Makar, et al.
Pageof 58